Toronto Stocks Pare Back; Canopy Growth Slides on $30 Million Fundraise by Private Placement
By Adriano Marchese
Stocks in Toronto were firmly lower Tuesday at midday. Most sectors were in the red in the session, with process industries the outsized laggard, followed by commercial services and utilities. Of the few gainers, health tech and investment trusts were the main leaders.
Canada's S&P/TSX Composite Index were down 0.57% to 20955.03 and the blue-chip S&P/TSX 60 fell by 0.62% to 1266.24.
Canopy Growth shares were lower by 9.2% at 6.12 Canadian dollars ($4.59) after the Canadian cannabis company said it intends to raise $30 million by way of a private placement with certain institutional investors, which it will use to reduce debt.
Other market movers:
K92 Mining's shares rose by 8.9% to C$6.76 after the Canadian miner's production beat its target for 2023, with record output at its Papua New Guinea mine in the final three months.
Endeavour Silver shares were up 3.7% to C$2.52 after it said that fourth-quarter output fell 23%, but in-line with its targets and said that recently-implemented initiatives to improve mine and mill productivity should help improve production.
Write to Adriano Marchese at adriano.marchese@wsj.com
(END) Dow Jones Newswires
January 09, 2024 12:18 ET (17:18 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
SiriusXM Earnings: Decent Results With Plan for Technology and Content Investment to Drive Growth
-
Coca-Cola Earnings: Solid Volume On Innovation and Digital Engagement
-
Is Berkshire Hathaway a Buy Before the Annual Meeting?
-
Investment Opportunities in the Drug Distribution Industry
-
Why the End of Quantitative Tightening Matters
-
Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins
-
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Boeing Stock a Buy, a Sell, or Fairly Valued?